Johnson & Johnson
Source: SEC Form 13F · as of Mar 2026Johnson & Johnson holds 11 biotech & pharma companies tracked by BioSniper, totaling $584.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$584.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Protagonist Therapeutics, Inc (PTGX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PTGXProtagonist Therapeutics, Inc | 2,449,183 | $258.1M |
| NBTXNanobiotix S.A. | 5,623,816 | $173.6M |
| MGTXMeiraGTx Holdings plc | 6,641,064 | $57.5M |
| RAPPRapport Therapeutics, Inc. | 1,784,517 | $55.8M |
| LEGNLegend Biotech Corp | 814,586 | $14.7M |
| XNCRXencor Inc | 748,062 | $9.0M |
| PRCTPROCEPT BioRobotics Corporation | 357,939 | $9.0M |
| FATEFATE THERAPEUTICS INC | 3,379,064 | $4.1M |
| RLYBRallybio Corp | 152,901 | $1.4M |
| VORVor Biopharma Inc. | 53,732 | $959K |
| ACETAdicet Bio, Inc. | 22,779 | $155K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.